GlucoTrack
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
301 Route 17 Ste 800, Rutherford, New Je...Phone Number
(201) 842-7715Website
www.glucotrack.comRevenue
-Stock Symbol
GCTKIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About GlucoTrack
Glucotrack, Inc. is a medical technology company headquartered in Rutherford, New Jersey, focused on the design, development, and commercialization of novel technologies for people with diabetes. Its primary program is a fully implantable Continuous Blood Glucose Monitor (CBGM) that measures glucose directly from the blood, aiming to eliminate external wearables and provide continuous monitoring for up to three years with minimal calibration. The company has completed preclinical and first-in-human studies and is pursuing regulatory approval, with additional research into applications such as painful diabetic neuropathy.Explore more
GlucoTrack Org Chart
VW
Chief Operating Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GlucoTrack your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if GlucoTrack has recently received funding, and reach out quickly before it becomes old news!
Check out if GlucoTrack is spiking on competitors!
Earning: See what the market has to say on GlucoTrack recently announced quarterly report
Funding: Get notified immidiatlly once GlucoTrack has new funding data
Congratulate Masked Content for being promoted to Masked Content at GlucoTrack
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if GlucoTrack had a recent Job posting/layoffs
GlucoTrack, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when GlucoTrack launches new products
Recommended Actions
Reach out to Masked Content who joined GlucoTrack as Masked Content
Find 3 more new buyers
Compare Similar Companies to GlucoTrack
Compare insights from companies similar to GlucoTrack, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GlucoTrack is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GlucoTrack is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GlucoTrack.
GlucoTrack financials insights
Gather financial insights about GlucoTrack, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$100K
2025
Private Equity
$20M
2026
Debt
$5.5M
Debt
$11.5M
GlucoTrack Tech Stack
A closer look at the technologies used by GlucoTrack
See more technologies
Most Recent Scoops
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
GlucoTrack is developing a fully implantable CGM system with no on-body wearable that lasts three years, compared to the one existing implantable device that lasts only one year and still requires an external wearable.
Product Development, Medical Research, Healthcare Technology
Project
GlucoTrack is developing a fully implantable CGM device with no on-body wearable, lasting for three years and measuring glucose directly in the blood. The device aims to overcome lag time issues during rapid glucose changes.
Product Development, Medical Research, Healthcare Technology
Project
Product Development, Medical Research, Healthcare Technology
GlucoTrack News & Media
Glucotrack Announces $11.5 Million Financing - GCTK - Stock Titan
The convertible debt carries a 22% original issue discount, converts initially at $3.12 per share and includes warrants exercisable at $7.50.Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances
Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq’s stockholders’ equity requirement, with the Nasdaq Hearings Panel granting the company’s request for continued listing subject to certain conditions. The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with all applicable Nasdaq standards.Glucotrack, Lōkahi secure financing for completed merger - Drug Delivery Business
Glucotrack (Nasdaq:GCTK) announced today that it secured a bridge financing to support the completion of its merger with Lōkahi Therapeutics.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GlucoTrack
Sign Up For FreeTo access detailed company insights
Glucotrack, Inc. is a medical technology company headquartered in Rutherford, New Jersey, focused on the design, development, and commercialization of novel technologies for people with diabetes. Its primary program is a fully implantable Continuous Blood Glucose Monitor (CBGM) that measures glucose directly from the blood, aiming to eliminate exte... Read More
